| Characteristic |
Boosteda n = 131 |
Unboostedb n = 34 |
Overall n = 165 |
| Age (mean ± SD) |
47 ± 9.6 |
44 ± 6.4 |
46 ± 9.1 |
Gender
Male, n (%)
Female, n (%) |
129 (98.5%)
2 (1.5%) |
34 (100%)
0 (0%) |
163 (98.8%)
2 (1.2%) |
Race
Asian, n (%)
Black, n (%)
Hispanic, n (%)
White, n (%) |
n/a
n/a
n/a
n/a |
n/a
n/a
n/a
n/a |
5 (3.0%)
12 (7.3%)
3 (1.8%)
145 (87.9%) |
Treatment duration in monthsc, median
(range) |
11 (1–17) |
19 (6–33) |
11 (133) |
Footnote: aall values in mg/dL
a300 mg atazanavir boosted with 100 mg ritonavir
b400 mg atazanavir given without ritonavir
cData available for 99 patients
SD, standard deviation
n/a, not available |
